IRIS
TISONE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 77.149
EU - Europa 5.063
AS - Asia 3.961
SA - Sud America 88
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 15
AF - Africa 8
Totale 86.304
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 77.117
SG - Singapore 1.771
CN - Cina 1.124
UA - Ucraina 1.049
DE - Germania 874
IE - Irlanda 818
IT - Italia 607
HK - Hong Kong 575
RU - Federazione Russa 538
SE - Svezia 323
GB - Regno Unito 279
KR - Corea 279
FI - Finlandia 236
FR - Francia 132
BR - Brasile 64
JP - Giappone 48
IN - India 38
NL - Olanda 38
PL - Polonia 37
ID - Indonesia 31
BE - Belgio 27
CA - Canada 27
VN - Vietnam 26
CZ - Repubblica Ceca 23
AT - Austria 21
TR - Turchia 16
EU - Europa 14
AU - Australia 13
CH - Svizzera 12
CL - Cile 9
GR - Grecia 9
IR - Iran 8
ES - Italia 7
RO - Romania 7
EG - Egitto 5
IL - Israele 5
BG - Bulgaria 4
KG - Kirghizistan 4
NO - Norvegia 4
TM - Turkmenistan 4
A1 - Anonimo 3
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
CO - Colombia 3
DM - Dominica 3
EC - Ecuador 3
IQ - Iraq 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
PE - Perù 3
SA - Arabia Saudita 3
DK - Danimarca 2
KH - Cambogia 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BZ - Belize 1
CY - Cipro 1
EE - Estonia 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MN - Mongolia 1
MV - Maldive 1
MX - Messico 1
NP - Nepal 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 86.304
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.750
Wilmington 21.185
Houston 18.825
Fairfield 2.243
Ann Arbor 1.946
Singapore 1.504
Chandler 1.185
Ashburn 1.014
Jacksonville 966
Seattle 952
Cambridge 834
Dublin 800
Medford 605
Hong Kong 568
Beijing 394
Santa Clara 381
Dearborn 330
Lawrence 284
Zhengzhou 281
Rome 243
New York 223
Mülheim 172
San Diego 146
Moscow 116
Menlo Park 95
Hangzhou 82
Milan 68
Council Bluffs 61
San Mateo 54
Shanghai 54
Creede 51
Redwood City 51
Palo Alto 49
University Park 49
Mountain View 46
Falls Church 39
Saint Petersburg 39
London 38
Los Angeles 38
Nanjing 37
Norwalk 37
Boardman 35
Guangzhou 34
Verona 33
Hefei 32
Jakarta 30
Kraków 30
Seoul 28
Engelhard 27
Helsinki 27
Munich 26
Nuremberg 25
Brussels 24
Kunming 23
São Paulo 18
Toronto 16
Nanchang 15
Hanoi 14
San Francisco 13
Amsterdam 12
Chengdu 12
Indiana 12
Chicago 11
Phoenix 11
Vienna 11
Brno 10
Enterprise 10
Frankfurt am Main 10
Hounslow 10
Detroit 9
Dong Ket 9
Fuzhou 9
Olomouc 9
Pune 9
Del Norte 8
Shenzhen 8
Washington 8
Aydin 7
Jinan 7
Lappeenranta 7
Nürnberg 7
Tokyo 7
Turin 7
Bologna 6
Chiswick 6
Civita Castellana 6
Colorado Springs 6
Islington 6
Monmouth Junction 6
Montreal 6
New Bedfont 6
Ningbo 6
Padova 6
Shenyang 6
Wuhan 6
Athens 5
Baotou 5
Buffalo 5
Changsha 5
Kilburn 5
Totale 79.602
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 514
Recurrence of insulin resistant metabolic syndrome following liver transplantation 460
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 458
Graft failure due to hemolytic uremic syndrome recurrence 450
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 448
Operational tolerance in clinical liver transplantation: emerging developments. 447
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 445
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 443
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 442
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 442
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 442
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 437
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 436
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 435
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 434
Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. 430
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 429
Is nephrectomy indicated in uremic patients with ADPKD waiting for transplant? 429
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 428
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 427
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft 426
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 423
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 423
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft. 422
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 421
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 420
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 419
Marginal donors in liver transplantation. 419
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 418
Leptin attenuates ischemia-reperfusion injury in the rat liver. 416
Infectious complications in renal transplant recipients 414
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 413
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 413
Conversion to rapamycin immunosuppression for malignancy after kidney transplantation 413
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 413
Liver abscess caused by foreign body ingestion 411
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 410
Flow cytometric analysis of antidonor-specific antibodies in liver transplant. 410
Hepatitis C reinfection after liver transplantation in relation to virus genotype 410
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 409
Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. 408
Clinical and neurophysiological evidence of polyneuropathy in liver transplant candidates: preliminary report. 407
Management of spermatic cord liposarcoma in renal transplant recipients: case report 406
596 406
Quality of life and long-term follow-up after kidney transplantation: a 30-year clinical study. 406
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 405
Graft failure due to hemolytic uremic syndrome recurrence 405
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 405
Metabolic findings after liver transplantation within a randomised trial with or without steroids 404
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 403
Spontaneous resolution of severe acute rejection in liver transplantation. 402
Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. 402
Phase I clinical trial with the AMC-bioartificial liver. 401
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 401
Multiparameter immune profiling of operational tolerance in liver transplantation. 400
Use of mycophenolate mofetil in liver transplantation: a literature review. 400
Ureteral obstruction in 140 renal transplant patients: preventions and treatment 400
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. 400
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 400
Surgical versus percutaneous technique for veno-venous bypass during orthotopic liver transplantation: a prospective randomized study. 399
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 399
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 399
Reduced acute rejection and side effects with neoral in liver transplantation. 399
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 398
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 397
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 396
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 396
Spontaneous resolution of severe acute rejection in liver transplantation 395
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: With or without steroids? 395
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report 394
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 394
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. 394
10-28 year follow-up in 23 patients with kideny traansplantation: immunosuppressive therapy, survival and complications 394
Kidney transplantation and pregnancy. 394
Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. 393
Characterization of γδ T cell subsets in organ transplantation. 393
Is donor age a risk factor for poor graft function after orthotopic liver transplantation? 392
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 391
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 391
Liver transplantation for end-stage liver disease related to viral hepatitis 390
Split-liver transplantation with pediatric donors: a multicenter experience. 388
Clinical Significance of de novo production of HLA of donor-specific antibodies in kidney transplantation. 387
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 386
Sequential changes in serum and biliary bile acids after liver transplantation 385
Endovascular treatment of giant splenic aneurysm that developed after liver transplantation. 385
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 385
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 383
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 383
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C 382
Average results and follow-up in 11 over-60 years of age kidney transplanted patients 382
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 382
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 380
Liver transplantation for the treatment of nodular regenerative hyperplasia 379
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European liver transplant registry 379
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids. 378
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 377
2.0 J Ti:sapphire laser oscillator. 376
Metabolic findings after liver transplantation within a randomised trial with or without steroids. 376
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 376
Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation 374
Totale 40.776
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011.136 0 0 0 0 0 0 1.856 1.939 1.953 2.072 1.495 1.821
2020/202114.048 1.631 1.745 1.600 1.826 1.358 1.522 1.715 1.365 311 307 496 172
2021/20222.847 106 305 94 159 79 327 134 123 273 313 123 811
2022/20233.564 377 290 81 371 278 809 327 324 300 23 294 90
2023/20241.316 146 40 189 24 140 307 53 41 35 66 24 251
2024/20254.546 256 1.682 834 487 142 582 563 0 0 0 0 0
Totale 87.212